Risk Factors Associated With Early Recurrence of Borderline Resectable Pancreatic Ductal Adenocarcinoma After Neoadjuvant Chemoradiation Therapy and Curative Resection
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.